News without an agenda. AP is a not-for-profit organization with no corporate parent, no shareholders and no government influence. Our mission is journalism, not profit margins. Your donation supports independent reporting that serves the public interest, not corporate shareholders. Donate today.

Why this matters:

• Trump has veered between venting that China, the world’s biggest buyer of Iranian oil, hasn’t done more to get the Islamic Republic in line, and acknowledging that Xi’s government helped de-escalate the conflict last month by nudging Tehran back to ceasefire talks when negotiations wobbled. Lately, the Trump administration seems determined not to let differences on Iran overshadow efforts to make headway on other difficult matters — ranging from trade to further Chinese cooperation to block exports of fentanyl precursors.

RELATED COVERAGE ➤

• What to know about Trump-Xi summit with trade, Taiwan and Iran on the agenda
  
  
• WATCH: Chinese people share mixed feelings about Trump’s visit
  
  
• Southern California mayor resigns, will plead guilty to acting as agent for Chinese government
  
  
• Hegseth is facing a new round of questioning from Congress on the Iran war and more
  
  
• WATCH: Iranian news agency posts new video said to show still-closed Strait of Hormuz
  
  
• Shipping industry fears fuel shortages as Iran war squeezes bunker fuel supply

US NEWS

Supreme Court temporarily extends women’s access to a widely used abortion pill

It is leaving women’s access to mifepristone untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug to take effect. Read more.

What to know:

• Justice Samuel Alito’s order Monday allows women seeking abortions to continue obtaining the pill at pharmacies or through the mail, without an in-person visit to a doctor. It prevents restrictions on mifepristone imposed by a federal appeals court from taking effect for the time being.
  
  

• The case before the court stems from a lawsuit Louisiana filed to roll back the Food and Drug Administration’s rules on how mifepristone can be prescribed. The state claims the policy undermines the ban there, and it questions the safety of the drug, which was first approved in 2000 and has repeatedly been deemed safe and effective by FDA scientists. In the current dispute, mainstream medical groups, the pharmaceutical industry and Democratic members of Congress have weighed in cautioning the court against limiting access to the drug. Pharmaceutical companies said a ruling for abortion opponents would upend the drug approval process.

RELATED COVERAGE ➤

• Supreme Court halts order for Alabama to use US House map with 2 largely Black districts
  
  
• Democrats ask the Supreme Court to halt a Virginia ruling blocking new congressional districts
  
  
• Missouri’s new US House map goes to court while Louisiana and South Carolina consider redistricting

POLITICS

Trump nominates Cameron Hamilton to lead FEMA, a year after his firing

It’s a notable comeback for the former Navy SEAL who was fired from his role as the Federal Emergency Management Agency’s temporary leader last year after he defended its existence. Read more.

Why this matters:

• His nomination comes as the Trump administration has increasingly signaled it is backing away from promises to dismantle FEMA, an agency that has faced withering criticism by the president. The nomination of Hamilton, who argued abolishing FEMA was not in the country’s best interests, is the latest indication of that change.
  
  

• If confirmed, he would take over an embattled agency still reeling from Kristi Noem’s turbulent leadership of the Department of Homeland Security, of which FEMA is part. FEMA’s workforce has been worn down by mass staff departures, policies that hamstrung operations and a 75-day-long DHS shutdown that ended April 30.